Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test

NCT ID NCT07046429

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This pilot study tests whether taking melatonin at night can increase REM sleep and improve cognitive function in people with cirrhosis who have a complication called hepatic encephalopathy (HE). Participants take melatonin for one month and a control supplement (thiamine) for another month, while wearing a sleep tracker and undergoing cognitive tests and sleep studies. The goal is to see if a simple, widely available supplement can help with the sleep disturbances and mental fog that often accompany advanced liver disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
melatonin 3 mg tablet taken nightly for 30 days, compared with thiamine 100 mg tablet as a control
What this could lead to
If it works, melatonin could offer a simple, low-cost way to improve sleep and brain function in people with cirrhosis and hepatic encephalopathy.
What could go wrong
This is a very small pilot study with only 18 participants, so results may not apply broadly. Melatonin can cause drowsiness, dizziness, or headaches, and its long-term effects in liver disease are not well studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NewYork-Presbyterian/Weill Cornell Medical Center

    RECRUITING

    New York, New York, 10021, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.